Literature DB >> 15022133

Airway inflammation in children with tracheostomy.

M Griese1, J Felber, K Reiter, P Strong, K Reid, B H Belohradsky, G Jäger, T Nicolai.   

Abstract

We hypothesised that long-term tracheostomy in infants and children may perpetuate chronic airway inflammation and airway remodeling due to easier access to the lungs for microorganisms. Pulmonary surfactant represents an important part of the initial host defense, and in particular, the surfactant proteins (SP) A and D may directly interact with invading microorganisms and also modulate the activity of local immune cells. The goals of this study were to determine the presence and intensity of a peripheral airway inflammation and of potential deficiency states of surfactant proteins in nonsymptomatic children with tracheostomy. Bronchoalveolar lavage (BAL) cell pattern, bacteria and viruses recovered, and concentrations of SP-A, SP-B, SP-C, and SP-D were assessed in 46 children (4.3 years (1.6-6)) median (range) carrying a tracheostomy for 2.4 years (1.3-4.9), and were compared to 16 children with no lung disease. Children with tracheostomy had an increased total number of cells, increased neutrophils, and more frequently bacteria, but no viruses were recovered. SP-D concentration was reduced by 50% on average (P = 0.0002). SP-A, SP-B, and SP-C were not different between the two groups. SP-D was inversely correlated to neutrophils, and high numbers of bacteria were associated with lower SP-D concentrations. We suggest that bacteria and low SP-D support neutrophilic inflammation in the lower respiratory tract of nonsymptomatic with children with tracheostomy. Copyright 2004 Wiely-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15022133     DOI: 10.1002/ppul.10432

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  8 in total

1.  Surfactant proteins in pediatric interstitial lung disease.

Authors:  Matthias Griese; Elke Lorenz; Meike Hengst; Andrea Schams; Traudl Wesselak; Daniela Rauch; Thomas Wittmann; Valerie Kirchberger; Amparo Escribano; Thomas Schaible; Winfried Baden; Johannes Schulze; Heiko Krude; Charalampos Aslanidis; Nicolaus Schwerk; Matthias Kappler; Dominik Hartl; Peter Lohse; Ralf Zarbock
Journal:  Pediatr Res       Date:  2015-09-16       Impact factor: 3.756

2.  Expression, regulation and clinical significance of soluble and membrane CD14 receptors in pediatric inflammatory lung diseases.

Authors:  Veronica Marcos; Phillip Latzin; Andreas Hector; Sebastian Sonanini; Florian Hoffmann; Martin Lacher; Barbara Koller; Philip Bufler; Thomas Nicolai; Dominik Hartl; Matthias Griese
Journal:  Respir Res       Date:  2010-03-19

Review 3.  Immunomodulatory roles of surfactant proteins A and D: implications in lung disease.

Authors:  Amy M Pastva; Jo Rae Wright; Kristi L Williams
Journal:  Proc Am Thorac Soc       Date:  2007-07

4.  Expression profiles of hydrophobic surfactant proteins in children with diffuse chronic lung disease.

Authors:  Matthias Griese; Silja Schumacher; Mohammed Tredano; Manuela Steinecker; Annika Braun; Susan Guttentag; Michael F Beers; Michel Bahuau
Journal:  Respir Res       Date:  2005-07-22

5.  Therapeutic lung lavages in children and adults.

Authors:  Christian Paschen; Karl Reiter; Franz Stanzel; Helmut Teschler; Matthias Griese
Journal:  Respir Res       Date:  2005-11-22

6.  Sequential analysis of surfactant, lung function and inflammation in cystic fibrosis patients.

Authors:  Matthias Griese; Robert Essl; Reinhold Schmidt; Manfred Ballmann; Karl Paul; Ernst Rietschel; Felix Ratjen
Journal:  Respir Res       Date:  2005-11-07

7.  A role for MCP-1/CCR2 in interstitial lung disease in children.

Authors:  Dominik Hartl; Matthias Griese; Thomas Nicolai; Gernot Zissel; Christine Prell; Dietrich Reinhardt; Dolores J Schendel; Susanne Krauss-Etschmann
Journal:  Respir Res       Date:  2005-08-11

8.  Reducing the frequency of respiratory tract infections in severe neurological disorders by inhaled antibiotics: a retrospective data analysis.

Authors:  Maximilian Eckerland; Claudia Bock; Margarete Olivier; Leopold Pichlmaier; Mathis Steindor; Florian Stehling
Journal:  ERJ Open Res       Date:  2019-07-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.